KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Accumulated Expenses (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Accumulated Expenses for 8 consecutive years, with $17.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 7.29% to $17.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.0 million through Dec 2025, up 7.29% year-over-year, with the annual reading at $17.0 million for FY2025, 7.29% up from the prior year.
  • Accumulated Expenses hit $17.0 million in Q4 2025 for Adaptive Biotechnologies, up from $12.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $17.0 million in Q4 2025 to a low of $154000.0 in Q4 2023.
  • Historically, Accumulated Expenses has averaged $10.2 million across 5 years, with a median of $10.0 million in 2022.
  • Biggest five-year swings in Accumulated Expenses: tumbled 99.03% in 2023 and later skyrocketed 10184.42% in 2024.
  • Year by year, Accumulated Expenses stood at $15.6 million in 2021, then rose by 1.87% to $15.9 million in 2022, then crashed by 99.03% to $154000.0 in 2023, then surged by 10184.42% to $15.8 million in 2024, then grew by 7.29% to $17.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for ADPT at $17.0 million in Q4 2025, $12.7 million in Q3 2025, and $7.2 million in Q2 2025.